Abstract
292: Paricalcitol Treatment in CKD Patients With Secondary Hyperparathyroidism Is Associated With Better Health Outcomes When Compared With No Vitamin D Receptor [VDR] Activator Treatment
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
